Roderick A Young

CIK 1365935 · last filed 2014-11-24

Roderick A Young is a corporate insider who has filed 6 SEC Form 4 insider transactions across 3 companies since 2007. Across all open-market trades the lifetime net is +$3.1M, making them a net buyer over the disclosed history. 2 SEC filings were submitted jointly with WILFRED E JAEGER.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

3

Total Filings

6

Lifetime Open-Market Net

$3.06M

Filer Profile

Reported Address
3200 ALPINE ROAD
PORTOLA VALLEY, CA 94028
Related Filers
WILFRED E JAEGER — 2 joint filings, latest 2008-01-28
THREE ARCH ASSOCIATES IV LP — 2 joint filings, latest 2008-01-28
Three Arch Management IV, L.L.C. — 2 joint filings, latest 2008-01-28
MARK A WAN — 2 joint filings, latest 2008-01-28
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
LIPOSCIENCE INC (LPDX) Delisted Director 1,122 $0 1 2013-06-14
BAXANO SURGICAL, INC. (BAXS) Delisted Director 3,608,230 $3.06M 1 2013-06-04
NORTH AMERICAN SCIENTIFIC INC (NASI) Delisted Director 26,223,495 $0 3 2008-05-01

Recent Filings

6 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2014-11-24 Disp (D) −10,077 -$52.9K
2013-06-14 LIPOSCIENCE INC (LPDX) Delisted Grant (A) +1,122 $0 EDGAR
2013-06-04 BAXANO SURGICAL, INC. (BAXS) Delisted Mixed +3,687,896 $3.06M EDGAR
2008-05-01 NORTH AMERICAN SCIENTIFIC INC (NASI) Delisted Mixed $0 EDGAR
2008-01-28 NORTH AMERICAN SCIENTIFIC INC (NASI) Delisted Grant (A) +406,504,200 $100.00M EDGAR
2007-06-07 NORTH AMERICAN SCIENTIFIC INC (NASI) Delisted Grant (A) $0 EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.